Task: Answer the multiple-choice question.
Question: Which compound exhibits a -13.324% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCN(Cc1cc2ccccc2[nH]c1=O)C(=O)C1CCCCC1
[b] Cc1ccccc1CC(=O)Nc1cccc(S(=O)(=O)N2CCCC2)c1
[c] CC1CCCN(c2ccc(C(=O)Nc3ccc4c(c3)OCO4)cc2[N+](=O)[O-])C1
Answer: a. CCN(Cc1cc2ccccc2[nH]c1=O)C(=O)C1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(Cc1cc2ccccc2[nH]c1=O)C(=O)C1CCCCC1
CCN(Cc1cc2ccccc2[nH]c1=O)C(=O)C1CCCCC1
N-ethyl-N-[(2-oxo-1H-quinolin-3-yl)methyl]cyclohexanecarboxamide